RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1600 Price Target
Benzinga Newsdesk 19 hours ago
Analyst RatingsNewsReiterationPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.
RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.
